Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jan;73(1):79–82. doi: 10.1038/bjc.1996.14

Induction of tumour cell shedding into effluent venous blood breast cancer surgery.

A Choy 1, P McCulloch 1
PMCID: PMC2074287  PMID: 8554988

Abstract

Surgeons have long been concerned that cancer may be disseminated by shedding of tumour cells into the bloodstream during surgery. Early claims that cancer operations induced an increase in the number of tumour cells shed into the circulation were subsequently discredited, and the issue has remained unresolved. We used immunocytochemistry for cytokeratins to detect tumour cells in effluent blood from breast carcinomas in 18 patients undergoing surgery. Tumour cells were detectable in 6/18 patients during surgery, in only one patient before operation and in none post-operatively (P = 0.025). Circulating cells were associated with vascular invasion within the primary tumour (P = 0.032). No cytokeratin-positive cells were found in blood from ten normal volunteers or four patients undergoing surgery for other breast conditions. These results confirm that cancer surgery in humans results in an increase in the shedding of tumour cells into the circulation. The implications for prognosis and practice should be determined by larger prospective studies.

Full text

PDF
79

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fidler I. J. 7th Jan Waldenström Lecture. The biology of human cancer metastasis. Acta Oncol. 1991;30(6):668–675. doi: 10.3109/02841869109092438. [DOI] [PubMed] [Google Scholar]
  2. Fisher B., Saffer E., Gunduz N., Coyle J., Rudock C. Serum growth factor following primary tumor removal and the inhibition of its production by preoperative therapy. Prog Clin Biol Res. 1990;354A:47–60. [PubMed] [Google Scholar]
  3. Glaves D., Huben R. P., Weiss L. Haematogenous dissemination of cells from human renal adenocarcinomas. Br J Cancer. 1988 Jan;57(1):32–35. doi: 10.1038/bjc.1988.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hart I. R., Saini A. Biology of tumour metastasis. Lancet. 1992 Jun 13;339(8807):1453–1457. doi: 10.1016/0140-6736(92)92039-i. [DOI] [PubMed] [Google Scholar]
  5. Herlyn M., Kath R., Williams N., Valyi-Nagy I., Rodeck U. Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro. Adv Cancer Res. 1990;54:213–234. doi: 10.1016/s0065-230x(08)60812-x. [DOI] [PubMed] [Google Scholar]
  6. Leather A. J., Gallegos N. C., Kocjan G., Savage F., Smales C. S., Hu W., Boulos P. B., Northover J. M., Phillips R. K. Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg. 1993 Jun;80(6):777–780. doi: 10.1002/bjs.1800800643. [DOI] [PubMed] [Google Scholar]
  7. Lennard T. W., Shenton B. K., Borzotta A., Donnelly P. K., White M., Gerrie L. M., Proud G., Taylor R. M. The influence of surgical operations on components of the human immune system. Br J Surg. 1985 Oct;72(10):771–776. doi: 10.1002/bjs.1800721002. [DOI] [PubMed] [Google Scholar]
  8. Liotta L. A., Saidel M. G., Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 1976 Mar;36(3):889–894. [PubMed] [Google Scholar]
  9. McCarthy J. B., Skubitz A. P., Iida J., Mooradian D. L., Wilke M. S., Furcht L. T. Tumor cell adhesive mechanisms and their relationship to metastasis. Semin Cancer Biol. 1991 Jun;2(3):155–167. [PubMed] [Google Scholar]
  10. Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982 Nov;31(1):11–24. doi: 10.1016/0092-8674(82)90400-7. [DOI] [PubMed] [Google Scholar]
  11. Pantel K., Izbicki J. R., Angstwurm M., Braun S., Passlick B., Karg O., Thetter O., Riethmüller G. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res. 1993 Mar 1;53(5):1027–1031. [PubMed] [Google Scholar]
  12. Salsbury A. J. The significance of the circulating cancer cell. Cancer Treat Rev. 1975 Mar;2(1):55–72. doi: 10.1016/s0305-7372(75)80015-6. [DOI] [PubMed] [Google Scholar]
  13. Sedman P. C., Ramsden C. W., Brennan T. G., Giles G. R., Guillou P. J. Effects of low dose perioperative interferon on the surgically induced suppression of antitumour immune responses. Br J Surg. 1988 Oct;75(10):976–981. doi: 10.1002/bjs.1800751012. [DOI] [PubMed] [Google Scholar]
  14. Tarin D., Price J. E., Kettlewell M. G., Souter R. G., Vass A. C., Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res. 1984 Aug;44(8):3584–3592. [PubMed] [Google Scholar]
  15. Wojtukiewicz M. Z., Tang D. G., Nelson K. K., Walz D. A., Diglio C. A., Honn K. V. Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface. Thromb Res. 1992 Nov 1;68(3):233–245. doi: 10.1016/0049-3848(92)90081-k. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES